<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24652348</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1470-2738</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of epidemiology and community health</Title><ISOAbbreviation>J Epidemiol Community Health</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>502</EndPage><MedlinePgn>500-2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jech-2014-203836</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabanathan</LastName><ForeName>Saraswathy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, , Ho Chi Minh City, Viet Nam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Le Van</ForeName><Initials>le V</Initials></Author><Author ValidYN="Y"><LastName>Thwaites</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Wills</LastName><ForeName>Bridget</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Qui</LastName><ForeName>Phan Tu</ForeName><Initials>PT</Initials></Author><Author ValidYN="Y"><LastName>Rogier van Doorn</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>101104</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Epidemiol Community Health</MedlineTA><NlmUniqueID>7909766</NlmUniqueID><ISSNLinking>0143-005X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001210" MajorTopicYN="N" Type="Geographic">Asia, Southeastern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002160" MajorTopicYN="N" Type="Geographic">Cambodia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Developing Countr</Keyword><Keyword MajorTopicYN="N">Epidemics</Keyword><Keyword MajorTopicYN="N">International Hlth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24652348</ArticleId><ArticleId IdType="pmc">PMC4033151</ArticleId><ArticleId IdType="doi">10.1136/jech-2014-203836</ArticleId><ArticleId IdType="pii">jech-2014-203836</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Severe complications of hand, foot and mouth disease (HFMD) caused by EV-71 in Cambodia&#x2014;conclusion of the joint investigation. 2012. 
[cited 31 Dec 2013]. http://www.who.int/csr/don/2012_07_13/en/</Citation></Reference><Reference><Citation>WHO. WPRO Hand, Foot and Mouth Disease Situation Update, 29 Jan 2014. 29 Jan 2014 [cited 29 Jan 2014]. http://www.wpro.who.int/emerging_diseases/HFMD/en/index.html</Citation></Reference><Reference><Citation>Seddon JH. Research Newsletter, Research Committee of the New Zealand Council, College of General Practitioners. 1961;2</Citation></Reference><Reference><Citation>Tee KK, Lam TT, Chan YF, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010;84:3339&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru Y, Nakano S, Yamaoka K, et al. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child 1980;55:583&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1627055</ArticleId><ArticleId IdType="pubmed">6254449</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010;10:778&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999;341:929&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis 2014; S1473-3099:70342-6. Epub ahead of print</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogon A, Spigland I, Frothingham TE, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 1969;89:51&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">5762818</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran CB, Nguyen HT, Phan HT, et al. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS One 2011;6:e21116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134465</ArticleId><ArticleId IdType="pubmed">21765891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis 2009;9:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637878</ArticleId><ArticleId IdType="pubmed">19152683</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Jan 2014 [cited 13 Feb 2014]. http://www.who.int</Citation></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007;356:1226&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gau SS, Chang LY, Huang LM, et al. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics 2008;122:e452&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">18606624</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A guide to clinical management and public health response for Hand, Foot and Mouth Disease (HFMD). Geneva, Switzerland: WHO Press, 2011</Citation></Reference><Reference><Citation>Chi CY, Khanh TH, Thoa LP, et al. Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial*. Crit Care Med 2013;41:1754&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">23685637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter LA, Gibbins KJ. Magnesium sulfate: past, present, and future. J Midwifery Womens Health 2011;56:566&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">22060216</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites CL, Yen LM, Cordon SM, et al. Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus. Anaesthesia 2008;63:719&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pubmed">18582257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001&#x2013;2007. Ann Acad Med Singapore 2009;38:106&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013;381:2024&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014;370:818&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, et al. An Inactivated Enterovirus 71 Vaccine in Healthy Children. N Engl J Med 2014;370:829&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>